![](https://i-invdn-com.investing.com/redesign/images/seo/investingcom_analysis_og.jpg)
Pfizer Targets $100 Billion Weight Loss Market With New Drug
Pharmaceutical giant Pfizer (NYSE:PFE) announced Thursday its decision to move forward with the development of a once-daily version of its weight loss pill, danuglipron, sparking a positive response from investors. The company’s stock rose 1.09% to $28.66 …